Omega oils and fish lower the risk of AMD in women.

Article

Regular intake of omega-3 fatty acids and fish is linked to a significant reduction in the risk of AMD, according to a study published in the Archives of Ophthalmology.

Regular intake of omega-3 fatty acids and fish is linked to a significant reduction in the risk of AMD, according to a study published in the Archives of Ophthalmology.

A team led by Dr William G. Christen, Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, asked 38 022 women to complete a food-frequency questionnaire. The outcome measures were best-corrected visual acuity to 20/30 or worse based on self-report confirmed by medical record review.

The results, after 10 years of follow-up, confirmed that women in the highest percentile of docosahexaenoic acid consumption, compared with those in the lowest, had a multivariate-adjusted relative risk of AMD of 0.62. For eicosapentaenoic the risk of AMD was 0.66.

The consumption of omega-3 fatty acids such as docosahexaenoic acid and eicosapentaenoic acid could be beneficial in the primary prevention of AMD.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.